Researchers at the ICR and The Royal Marsden have been named in a list of the world's most influential researchers.

A major new study of more than 140,000 men has identified 63 new genetic variations in the DNA code that increase the risk of prostate cancer.

Scientists have identified 80 molecular weaknesses in prostate cancer that could be targeted by drugs – in the largest, most comprehensive study ever conducted into the genes that drive the disease.